Found 3624 matching trials
Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer
PHASE3This was a national, multi-center, open-label, phase IIIb trial to determin...
Location
Novartis Investigative Site
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
PHASE3The purpose of this study is to evaluate the safety and efficacy of the stu...
Status
Active Not Recruiting
Location
University of Alabama Birmingham
Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)
PHASE2To determine the activity of lenalidomide in relapsed or refractory aggress...
Location
Mayo Clinic Scottsdale
Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML
PHASE3This study aims to evaluate the efficacy and safety of venetoclax combined ...
Location
The First Affiliated Hospital of Anhui Medical University
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
PHASE1The main purpose of this study is to find out the most suitable dose (recom...
Location
New York University Langone Medical Center
Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
PHASE2This phase II, open-label, multicenter study evaluates zanubrutinib in pati...
Bevacizumab Injection for Recurrent Pterygium
N/ABlockade of vascular endothelial growth factor (VEGF) with bevacizumab has ...
Location
Institute of Ophthalmology, Conde de Valenciana Foundation
Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
PHASE2The purpose of this research study is to see if people whose Acute myeloid ...
Location
Moffitt Cancer Center
MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma
PHASE1The purpose of this study is to determine the maximum tolerated dose and ef...
Location
Mayo Clinic Arizona
Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer
PHASE2This is an open-label, single-arm, single-center,exploratory clinical study...
Location
Multiple Locations